Clinical Trials
52 trialsTIL
University Hospital, Rouen
COCA-MACS
University Hospital, Rouen
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
Wake Forest University Health Sciences
PREDICT-IRFC
Centre Hospitalier Universitaire de Besancon
ELEPHAS-04
Mayo Clinic
Neocolon
Osijek University Hospital
COLODIAG
University Hospital, Rouen
FECCO-BioBank
University Hospital, Montpellier
COCO-S
Nordsjaellands Hospital
Glutamine PET Imaging Colorectal Cancer
M.D. Anderson Cancer Center
MICROCOL
Assistance Publique Hopitaux De Marseille
CTC
University Hospital, Rouen
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
ADVANCED MARKER DISCOVERY S.L.
SMART
Erasmus Medical Center
ESCAPE
Erasmus Medical Center
POSTEx
University of Nottingham
PROGRESS
UNC Lineberger Comprehensive Cancer Center
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
University Hospital, Montpellier
AACRC
City of Hope Medical Center
MS-Prevecol
ADVANCED MARKER DISCOVERY S.L.
GIMICC
University Medical Center Groningen
CARE
Centre Hospitalier Universitaire de Besancon
REPROGRAM-02
Centre Hospitalier Universitaire de Besancon
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
Peking University Cancer Hospital & Institute
Epigenetic Regulation of Colorectal Polyps and Cancer
Region Skane
French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
University Hospital, Montpellier
Chemerin in Colorectal Cancer and Its Relationship With Diet Quality
Hacettepe University
Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases
Tampere University Hospital
EMBRaCE-GM
Manchester University NHS Foundation Trust
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
COLOFIT
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
EXOSCOL01
CHU de Reims
COLODIAG pre
Centre Hospitalier Universitaire Dijon
Circulating Tumor Material in Colorectal Cancer and Melanoma
Abramson Cancer Center at Penn Medicine
CORIOLAN
Jules Bordet Institute
ONCOPRO
Hospices Civils de Lyon
Tumoral Circulating Cells and Colorectal Cancer Progression
Institut Paoli-Calmettes
Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)
National University Hospital, Singapore
Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients
National Cancer Institute, Egypt
DPD côlon
Institut Cancerologie de l'Ouest
PASCAL
Clinical Genomics Pathology
The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal Cancer
Fakultas Kedokteran Universitas Indonesia
Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression
Yonsei University
ANC2
Hospices Civils de Lyon
BIOCOR
Hasselt University
Coca-Colon
University Hospital, Rouen
AVECC
Centre Leon Berard
Pharmacokinetics and Metabolic Activation of Capecitabine
Arbeitsgemeinschaft medikamentoese Tumortherapie
PRESEPT
Epigenomics, Inc
SPR0012
Epigenomics, Inc